Reported Earnings • Mar 17
Full year 2025 earnings released: EPS: ₩128 (vs ₩157 in FY 2024) Full year 2025 results: EPS: ₩128 (down from ₩157 in FY 2024). Revenue: ₩77.5b (up 4.9% from FY 2024). Net income: ₩2.51b (down 19% from FY 2024). Profit margin: 3.2% (down from 4.2% in FY 2024). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has fallen by 40% per year but the company’s share price has only fallen by 12% per year, which means it has not declined as severely as earnings. Aankondiging • Mar 10
InkTec Co., Ltd., Annual General Meeting, Mar 25, 2026 InkTec Co., Ltd., Annual General Meeting, Mar 25, 2026, at 09:01 Tokyo Standard Time. Location: conference room, 98-12, neungan-ro, danwon-gu, gyeonggi-do, ansan South Korea New Risk • Feb 10
New minor risk - Share price stability The company's share price has been volatile over the past 3 months. It is more volatile than 75% of South Korean stocks, typically moving 9.9% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Minor Risks Share price has been volatile over the past 3 months (9.9% average weekly change). Market cap is less than US$100m (₩69.3b market cap, or US$47.4m). Reported Earnings • Nov 19
Third quarter 2025 earnings released: ₩110 loss per share (vs ₩19.00 profit in 3Q 2024) Third quarter 2025 results: ₩110 loss per share (down from ₩19.00 profit in 3Q 2024). Revenue: ₩19.4b (up 5.7% from 3Q 2024). Net loss: ₩2.15b (down ₩2.51b from profit in 3Q 2024). Over the last 3 years on average, earnings per share has fallen by 47% per year but the company’s share price has only fallen by 21% per year, which means it has not declined as severely as earnings. New Risk • May 23
New minor risk - Earnings quality The company has large one-off items impacting its financial results. One-off items were 29% of the size of the rest of the company's trailing 12-month earnings before tax. This is considered a minor risk. One-off items are incomes or expenses that the company does not expect to repeat in future periods. Examples include profits from the sale of a business or expenses from a restructuring or legal settlements. If the company's reported statutory earnings include a large proportion of one-off items it means they may be an unreliable indicator of its true business performance as the earnings were skewed by these incomes or expenses. Currently, the following risks have been identified for the company: Major Risk Interest payments are not well covered by earnings (2.7x net interest cover). Minor Risks Large one-off items impacting financial results. Profit margins are more than 30% lower than last year (2.1% net profit margin). Market cap is less than US$100m (₩68.4b market cap, or US$49.8m). Reported Earnings • Mar 13
Full year 2024 earnings released: EPS: ₩157 (vs ₩189 in FY 2023) Full year 2024 results: EPS: ₩157 (down from ₩189 in FY 2023). Revenue: ₩73.9b (up 18% from FY 2023). Net income: ₩3.08b (down 17% from FY 2023). Profit margin: 4.2% (down from 5.9% in FY 2023). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 2% per year but the company’s share price has fallen by 19% per year, which means it is significantly lagging earnings. Aankondiging • Mar 11
InkTec Co., Ltd., Annual General Meeting, Mar 26, 2025 InkTec Co., Ltd., Annual General Meeting, Mar 26, 2025, at 09:00 Tokyo Standard Time. Location: conference room, 98-12, neungan-ro, danwon-gu, gyeonggi-do, ansan South Korea New Risk • Sep 17
New major risk - Financial data availability The company has not reported any financial data. This is considered a major risk. With no or incomplete audited reported financial data, it is virtually impossible to assess the company's investment potential. Currently, the following risks have been identified for the company: Major Risk No financial data reported. Minor Risk Market cap is less than US$100m (₩76.3b market cap, or US$58.0m). Reported Earnings • Aug 17
Second quarter 2024 earnings released: EPS: ₩91.00 (vs ₩12.00 in 2Q 2023) Second quarter 2024 results: EPS: ₩91.00 (up from ₩12.00 in 2Q 2023). Revenue: ₩18.8b (up 19% from 2Q 2023). Net income: ₩1.78b (up ₩1.55b from 2Q 2023). Profit margin: 9.5% (up from 1.5% in 2Q 2023). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 37% per year but the company’s share price has fallen by 21% per year, which means it is significantly lagging earnings. Valuation Update With 7 Day Price Move • May 13
Investor sentiment improves as stock rises 15% After last week's 15% share price gain to ₩4,280, the stock trades at a trailing P/E ratio of 22.6x. Average trailing P/E is 16x in the Chemicals industry in South Korea. Total loss to shareholders of 47% over the past three years. Reported Earnings • Mar 13
Full year 2023 earnings released: EPS: ₩189 (vs ₩202 in FY 2022) Full year 2023 results: EPS: ₩189 (down from ₩202 in FY 2022). Revenue: ₩62.8b (up 2.1% from FY 2022). Net income: ₩3.71b (down 6.3% from FY 2022). Profit margin: 5.9% (down from 6.4% in FY 2022). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 61% per year but the company’s share price has fallen by 17% per year, which means it is significantly lagging earnings. New Risk • Mar 13
New major risk - Financial position The company's debt is not well covered by operating cash flow. Operating cash flow to total debt ratio: 12% This is considered a major risk. If the company's operating cash flows are too small relative to the size of their debt, it increases their balance sheet risk. The company has less cash from operations to cover its expenses from servicing large debt and it increases the risk of liquidity issues. It also extends the time it would take for the company to pay back the debt in full, meaning it may not be able to easily pay it all off in a distress scenario. Currently, the following risks have been identified for the company: Major Risk Debt is not well covered by operating cash flow (12% operating cash flow to total debt). Minor Risk Market cap is less than US$100m (₩71.6b market cap, or US$54.6m). Reported Earnings • Nov 19
Third quarter 2023 earnings released: EPS: ₩48.00 (vs ₩49.00 in 3Q 2022) Third quarter 2023 results: EPS: ₩48.00 (down from ₩49.00 in 3Q 2022). Revenue: ₩16.0b (up 6.3% from 3Q 2022). Net income: ₩933.0m (down 2.9% from 3Q 2022). Profit margin: 5.8% (down from 6.4% in 3Q 2022). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 77% per year but the company’s share price has only increased by 4% per year, which means it is significantly lagging earnings growth. Valuation Update With 7 Day Price Move • May 09
Investor sentiment improves as stock rises 23% After last week's 23% share price gain to ₩5,640, the stock trades at a trailing P/E ratio of 27.9x. Average trailing P/E is 14x in the Chemicals industry in South Korea. Total returns to shareholders of 59% over the past three years. Reported Earnings • Mar 09
Full year 2022 earnings released: EPS: ₩202 (vs ₩91.00 in FY 2021) Full year 2022 results: EPS: ₩202 (up from ₩91.00 in FY 2021). Revenue: ₩61.5b (up 12% from FY 2021). Net income: ₩3.96b (up 137% from FY 2021). Profit margin: 6.4% (up from 3.0% in FY 2021). Over the last 3 years on average, earnings per share has increased by 107% per year but the company’s share price has only increased by 19% per year, which means it is significantly lagging earnings growth. Board Change • Nov 16
No independent directors No new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 7 experienced directors. No highly experienced directors. No independent directors (7 non-independent directors). was the last director to join the board, commencing their role in . The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of independent directors. Insufficient board refreshment. Reported Earnings • Nov 09
Third quarter 2022 earnings released: EPS: ₩49.00 (vs ₩86.00 in 3Q 2021) Third quarter 2022 results: EPS: ₩49.00 (down from ₩86.00 in 3Q 2021). Revenue: ₩15.0b (up 6.0% from 3Q 2021). Net income: ₩960.9m (down 40% from 3Q 2021). Profit margin: 6.4% (down from 11% in 3Q 2021). Over the last 3 years on average, earnings per share has increased by 102% per year but the company’s share price has only increased by 6% per year, which means it is significantly lagging earnings growth. Board Change • Apr 27
No independent directors No new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 7 experienced directors. No highly experienced directors. No independent directors (7 non-independent directors). was the last director to join the board, commencing their role in . The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of independent directors. Insufficient board refreshment. Reported Earnings • Mar 11
Full year 2021 earnings: Revenues and EPS in line with analyst expectations Full year 2021 results: EPS: ₩91.00 (up from ₩34.00 loss in FY 2020). Revenue: ₩55.2b (up 14% from FY 2020). Net income: ₩1.67b (up ₩2.22b from FY 2020). Profit margin: 3.0% (up from net loss in FY 2020). Revenue was in line with analyst estimates. Over the last 3 years on average, earnings per share has increased by 58% per year but the company’s share price has only increased by 30% per year, which means it is significantly lagging earnings growth. Aankondiging • Apr 03
InkTec Co., Ltd. announced that it has received KRW 12 billion in funding On April 1, 2021, InkTec Co., Ltd. (KOSDAQ:A049550) closed the transaction. Aankondiging • Mar 14
InkTec Co., Ltd. announced that it expects to receive KRW 12 billion in funding InkTec Co., Ltd. (KOSDAQ:A049550) announced a private placement of 2,400,000 shares at an issue price of KRW 500 per share for gross proceeds of KRW 12,000,000,000 on March 12, 2021. The company is raising funding through third party allotment method. The transaction is expected to close on April 1, 2021. The transaction has been approved by the board of directors. Reported Earnings • Mar 13
Full year 2020 earnings released: ₩34.00 loss per share (vs ₩177 loss in FY 2019) The company reported a decent full year result with reduced losses and improved control over expenses, although revenues were weaker. Full year 2020 results: Revenue: ₩48.3b (down 18% from FY 2019). Net loss: ₩544.0m (loss narrowed 81% from FY 2019). Over the last 3 years on average, earnings per share has increased by 64% per year but the company’s share price has only increased by 19% per year, which means it is significantly lagging earnings growth. Is New 90 Day High Low • Mar 05
New 90-day high: ₩4,900 The company is up 18% from its price of ₩4,155 on 04 December 2020. The South Korean market is up 10.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 9.0% over the same period. Is New 90 Day High Low • Dec 15
New 90-day high: ₩4,300 The company is up 41% from its price of ₩3,050 on 16 September 2020. The South Korean market is up 12% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 9.0% over the same period.